Terms: = Kidney tumors AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Clinical Outcome
19 results:
1. Predictive factors and prognosis of upper gastrointestinal bleeding in gastric cancer: A large population-based study (UGIB-GC trial).
Kiattiweerasak A; Bongkotvirawan P; Aumpan N; Yamaoka Y; Miftahussurur M; Vilaichone RK
PLoS One; 2023; 18(9):e0291926. PubMed ID: 37729185
[TBL] [Abstract] [Full Text] [Related]
2. Somatic-type Malignancies in Testicular Germ Cell tumors: A Clinicopathologic Study of 63 Cases.
Hwang MJ; Hamza A; Zhang M; Tu SM; Pisters LL; Czerniak B; Guo CC
Am J Surg Pathol; 2022 Jan; 46(1):11-17. PubMed ID: 34334690
[TBL] [Abstract] [Full Text] [Related]
3. Sunitinib in Patients With Metastatic Renal Cell Carcinoma: clinical outcome According to International Metastatic Renal Cell Carcinoma Database Consortium Risk Group.
Rini BI; Hutson TE; Figlin RA; Lechuga MJ; Valota O; Serfass L; Rosbrook B; Motzer RJ
Clin Genitourin Cancer; 2018 Aug; 16(4):298-304. PubMed ID: 29853320
[TBL] [Abstract] [Full Text] [Related]
4. clinical outcome of high-dose bolus intravenous interleukin-2 with a modified administration schedule for Asian patients with metastatic renal cell carcinoma.
Lee JY; Song C; Hong BS; Hong JH; Ahn H; Lee JL
Cancer Chemother Pharmacol; 2017 Jan; 79(1):173-180. PubMed ID: 28011979
[TBL] [Abstract] [Full Text] [Related]
5. High Throughput Kinomic Profiling of Human Clear Cell Renal Cell Carcinoma Identifies Kinase Activity Dependent Molecular Subtypes.
Anderson JC; Willey CD; Mehta A; Welaya K; Chen D; Duarte CW; Ghatalia P; Arafat W; Madan A; Sudarshan S; Naik G; Grizzle WE; Choueiri TK; Sonpavde G
PLoS One; 2015; 10(9):e0139267. PubMed ID: 26406598
[TBL] [Abstract] [Full Text] [Related]
6. Septin 9 amplification and isoform-specific expression in peritumoral and tumor breast tissue.
Connolly D; Hoang HG; Adler E; Tazearslan C; Simmons N; Bernard VV; Castaldi M; Oktay MH; Montagna C
Biol Chem; 2014 Feb; 395(2):157-67. PubMed ID: 24127542
[TBL] [Abstract] [Full Text] [Related]
7. Is adrenalectomy necessary during unilateral nephrectomy for Wilms Tumor? A report from the Children's Oncology Group.
Kieran K; Anderson JR; Dome JS; Ehrlich PF; Ritchey ML; Shamberger RC; Perlman EJ; Green DM; Davidoff AM
J Pediatr Surg; 2013 Jul; 48(7):1598-603. PubMed ID: 23895979
[TBL] [Abstract] [Full Text] [Related]
8. Impact of age on treatment trends and clinical outcome in patients with metastatic renal cell carcinoma.
Pal SK; Hsu J; Hsu S; Hu J; Bergerot P; Carmichael C; Saikia J; Liu X; Lau C; Twardowski P; Figlin RA; Yuh BF
J Geriatr Oncol; 2013 Apr; 4(2):128-33. PubMed ID: 23646100
[TBL] [Abstract] [Full Text] [Related]
9. The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients.
Al-Marrawi MY; Rini BI; Harshman LC; Bjarnason G; Wood L; Vaishampayan U; MacKenzie M; Knox JJ; Agarwal N; Al-Harbi H; Kollmannsberger C; Tan MH; Rha SY; Donskov FN; North S; Choueiri TK; Heng DY;
Target Oncol; 2013 Sep; 8(3):203-209. PubMed ID: 23300029
[TBL] [Abstract] [Full Text] [Related]
10. clinical outcome in patients receiving systemic therapy for metastatic sarcomatoid renal cell carcinoma: a retrospective analysis.
Pal SK; Jones JO; Carmichael C; Saikia J; Hsu J; Liu X; Figlin RA; Twardowski P; Lau C
Urol Oncol; 2013 Nov; 31(8):1826-31. PubMed ID: 22608544
[TBL] [Abstract] [Full Text] [Related]
11. Small cell carcinoma of the kidney: a clinicopathologic study of 14 cases.
Si Q; Dancer J; Stanton ML; Tamboli P; Ro JY; Czerniak BA; Shen SS; Guo CC
Hum Pathol; 2011 Nov; 42(11):1792-8. PubMed ID: 21733553
[TBL] [Abstract] [Full Text] [Related]
12. Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer.
Mertz KD; Demichelis F; Sboner A; Hirsch MS; Dal Cin P; Struckmann K; Storz M; Scherrer S; Schmid DM; Strebel RT; Probst-Hensch NM; Gerstein M; Moch H; Rubin MA
Int J Cancer; 2008 Aug; 123(3):569-76. PubMed ID: 18478571
[TBL] [Abstract] [Full Text] [Related]
13. Pulmonary resection for non-small-cell lung cancer in patients on hemodialysis: clinical outcome and long-term results.
Ciriaco P; Casiraghi M; Melloni G; Carretta A; Libretti L; Augello G; Zannini P
World J Surg; 2005 Nov; 29(11):1516-9. PubMed ID: 16222451
[TBL] [Abstract] [Full Text] [Related]
14. Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma.
Breault JE; Shiina H; Igawa M; Ribeiro-Filho LA; Deguchi M; Enokida H; Urakami S; Terashima M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):557-64. PubMed ID: 15701841
[TBL] [Abstract] [Full Text] [Related]
15. Prednisolone and azathioprine in IgA nephropathy - a ten-year follow-up study.
Goumenos DS; Davlouros P; El Nahas AM; Ahuja M; Shortland JR; Vlachojannis JG; Brown CB
Nephron Clin Pract; 2003; 93(2):C58-68. PubMed ID: 12616032
[TBL] [Abstract] [Full Text] [Related]
16. Allelic loss on chromosomes 8 and 9 correlates with clinical outcome in locally advanced clear cell carcinoma of the kidney.
Presti JC; Wilhelm M; Reuter V; Russo P; Motzer R; Waldman F
J Urol; 2002 Mar; 167(3):1464-8. PubMed ID: 11832771
[TBL] [Abstract] [Full Text] [Related]
17. A randomized phase II trial comparing two different sequence combinations of autologous vaccine and human recombinant interferon gamma and human recombinant interferon alpha2B therapy in patients with metastatic renal cell carcinoma: clinical outcome and analysis of immunological parameters.
Schwaab T; Heaney JA; Schned AR; Harris RD; Cole BF; Noelle RJ; Phillips DM; Stempkowski L; Ernstoff MS
J Urol; 2000 Apr; 163(4):1322-7. PubMed ID: 10737537
[TBL] [Abstract] [Full Text] [Related]
18. The prognostic significance of immune changes in patients with renal cancer, melanoma and colorectal cancer, treated with interferon alpha 2b.
Tsavaris N; Baxevanis C; Kosmidis P; Papamichael M
Cancer Immunol Immunother; 1996 Oct; 43(2):94-102. PubMed ID: 8954143
[TBL] [Abstract] [Full Text] [Related]
19. Natural immune reactivity-associated therapeutic response in patients with metastatic renal cell carcinoma receiving tumor-infiltrating lymphocytes and interleukin-2-based therapy.
Belldegrun A; Tso CL; Kaboo R; Pang S; Pierce W; deKernion JB; Figlin R
J Immunother Emphasis Tumor Immunol; 1996 Mar; 19(2):149-61. PubMed ID: 8732698
[TBL] [Abstract] [Full Text] [Related]
